Cite
HARVARD Citation
Montenigro, P. et al. (n.d.). ENVISION: Increasing diversity of a large phase 3b/4 confirmatory trial of aducanumab to better understand the efficacy and safety among historically underrepresented participants of Alzheimer's disease research and clinical trials.. Alzheimer's & dementia. p. n/a. [Online].